drugset / Trial / NCT05360615
The Effects of Empagliflozin on Renal Outcomes in Post Severe Acute Kidney Injury Survivors
RandomizedParallel-groupQuadruple-blindTreatment
Summary
Effects of Empagliflozin compared with placebo in post severe acute kidney injury survivors, evaluated by MAKE365.
Timeline
- Start
- 2022-07-01
- Primary completion
- 2024-06-01
- Completion
- 2026-07-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Empagliflozin | Small molecule | 10 mg | — |
Indications
No indication recorded.